12 Week Comparison of 5 Mcg and 10 Mcg of Tiotropium / Respimat, Placebo and Ipratropium MDI in COPD

Completed · Phase 3

Conditions studied: Pulmonary Disease, Chronic Obstructive

In brief

The primary objective was to compare the bronchodilator efficacy of two doses (5 mcg and 10 mcg) of tiotropium inhalation solution delivered by the Respimat inhaler once daily to placebo and to ipratropium bromide MDI four times daily in patients with COPD. The secondary objective was to compare the safety of tiotropium inhalation solution delivered by the Respimat to placebo and ipratropium bromide MDI.

Key facts

Study ID

NCT00240435

Run by

Boehringer Ingelheim

People needed

491

Starts

2002-11-01

Last updated by the study team

2013-11-01

Who can join

Age: 40 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Boehringer Ingelheim Investigational Site — Birmingham, Alabama, United States
• Boehringer Ingelheim Investigational Site — Downey, California, United States
• University of California - Los Angeles — Los Angeles, California, United States
• Boehringer Ingelheim Investigational Site — Palo Alto, California, United States
• Rocky Mountain Center for Clinical Research — Wheat Ridge, Colorado, United States
• Boehringer Ingelheim Investigational Site — Bay Pines, Florida, United States
• Boehringer Ingelheim Investigational Site — Clearwater, Florida, United States
• Boehringer Ingelheim Investigational Site — Pembroke Pines, Florida, United States
• Boehringer Ingelheim Investigational Site — Wheaton, Maryland, United States
• Boehringer Ingelheim Investigational Site — St Louis, Missouri, United States
• Boehringer Ingelheim Investigational Site — New Hyde Park, New York, United States
• Boehringer Ingelheim Investigational Site — Elizabeth City, North Carolina, United States
• Boehringer Ingelheim Investigational Site — Charleston, South Carolina, United States
• Boehringer Ingelheim Investigational Site — Dallas, Texas, United States
• Boehringer Ingelheim Investigational Site — Vancouver, British Columbia, Canada
• St. Boniface General Hospital — Winnipeg, Manitoba, Canada
• Boehringer Ingelheim Investigational Site — Courtice, Ontario, Canada
• St. Joseph's Hospital Cardiac Research — Hamilton, Ontario, Canada
• Boehringer Ingelheim Investigational Site — Toronto, Ontario, Canada
• Department of Respiratory Medicine — Toronto, Ontario, Canada
• Toronto General Hospital — Toronto, Ontario, Canada
• SMBD--Jewish General Hospital — Montreal, Quebec, Canada
• Centre de Recherche Clinique -CUSE — Sherbrooke, Quebec, Canada
• Hopital Laval — Ste-Foy, Quebec, Canada
• c/o Hemodynamics Offices — Saskatoon, Saskatchewan, Canada

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.